Urgent.News

600+ sources. One page. See who else covered it.

Editions

Health & Medicine

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

A unanimous 3-judge panel ruled that UMB Bank had standing to represent former Celgene shareholders despite a procedural error in its appointment

Appeals court revived a $6.7 billion lawsuit against Bristol Myers Squibb over delayed drug approvals

We haven't written up this one. Quartz has the full story — the link below goes straight to it.

This story

This is one outlet's version. Read the fullest account.

Read the original at qz.com →

More in Health & Medicine

More from Thursday 13 August →